Huntington's Disease (hd) Clinical Trials
2 recruiting trials for Huntington's Disease (hd). Eligibility criteria explained in plain English.
TrialFinderData lists 2 Huntington's Disease (hd) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Rush University Medical Center (1), University Hospital, Angers (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Social Cognition Training (behavioral, 1 trial), followed by Synergistic management, Sequential management.
Track Huntington's Disease (hd) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Social Cognition Training in Individuals With Huntington's Disease
Individuals with Huntington's Disease have impaired social cognition, which is the domain of cognition that allows individuals to understand others' perspectives so that they can...
Comparison of Two Cognitive-Motor Rehabilitation Approaches Via Exergames: a Study of Cognitive, Motor and Behavioral...
Huntington's disease (HD) is a rare, hereditary neurodegenerative disorder. It generally manifests itself between the ages of 40 and 50, and results in motor impairment (choreic...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Huntington's Disease (hd), with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Huntington's Disease (hd), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Huntington's Disease (hd), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.